These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7897460)

  • 1. Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction.
    Matts JP; Buchwald H; Fitch LL; Campos CT; Varco RL; Campbell GS; Pearce MB; Yellin AE; Smink RD; Sawin HS
    J Clin Epidemiol; 1995 Mar; 48(3):389-405. PubMed ID: 7897460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Varco RL; Boen JR; Williams SE; Hansen BJ; Campos CT; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD; Sawin HS
    Arch Intern Med; 1998 Jun; 158(11):1253-61. PubMed ID: 9625405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-based mortality follow-up from the Program on the Surgical Control of the Hyperlipidemias (POSCH) and meta-analysis of lipid intervention trials. Women in POSCH and other lipid trials.
    Buchwald H; Campos CT; Boen JR; Nguyen P; Williams SE; Lau J; Chalmers TC
    Ann Surg; 1996 Oct; 224(4):486-98; discussion 498-500. PubMed ID: 8857853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH Group.
    Buchwald H; Matts JP; Fitch LL; Varco RL; Campbell GS; Pearce M; Yellin A; Smink RD; Sawin HS; Campos CT
    J Clin Epidemiol; 1989; 42(12):1111-27. PubMed ID: 2685177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Program on the surgical control of the hyperlipidemias: 1994 report.
    Buchwald H; Campos CT
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S3-10. PubMed ID: 8907208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Campos CT; Boen JR; Nguyen PA; Williams SE
    J Am Coll Cardiol; 1995 Aug; 26(2):351-7. PubMed ID: 7608434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women in the POSCH trial. Effects of aggressive cholesterol modification in women with coronary heart disease. The POSCH Group. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Campos CT; Matts JP; Fitch LL; Long JM; Varco RL
    Ann Surg; 1992 Oct; 216(4):389-98; discussion 398-400. PubMed ID: 1417188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH Group.
    Matts JP; Buchwald H; Fitch LL; Campos CT; Varco RL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    Control Clin Trials; 1991 Apr; 12(2):314-39. PubMed ID: 1645643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aspirin use on death and recurrent myocardial infarction in current and former cigarette smokers. Program on the Surgical Control of the Hyperlipidemias Group.
    Fitch LL; Buchwald H; Matts JP; Johnson JW; Campos CT; Long JM
    Am Heart J; 1995 Apr; 129(4):656-62. PubMed ID: 7900613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias.
    Buchwald H; Rudser KD; Williams SE; Michalek VN; Vagasky J; Connett JE
    Ann Surg; 2010 Jun; 251(6):1034-40. PubMed ID: 20485136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall mortality in the program on the surgical control of the hyperlipidemias.
    Buchwald H; Williams SE; Matts JP; Nguyen PA; Boen JR
    J Am Coll Surg; 2002 Sep; 195(3):327-31. PubMed ID: 12229939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perception of quality of life before and after disclosure of trial results: a report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Fitch LL; Matts JP; Johnson JW; Hansen BJ; Stuenkel MR; Brooks HB
    Control Clin Trials; 1993 Dec; 14(6):500-10. PubMed ID: 8119065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group.
    Buchwald H; Matts JP; Fitch LL; Campos CT; Sanmarco ME; Amplatz K; Castaneda-Zuniga WR; Hunter DW; Pearce MB; Bissett JK
    JAMA; 1992 Sep; 268(11):1429-33. PubMed ID: 1512911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. POSCH Group.
    Matts JP; Karnegis JN; Campos CT; Fitch LL; Johnson JW; Buchwald H
    J Fam Pract; 1993 May; 36(5):497-503. PubMed ID: 8482933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipids and cardiovascular risk: a POSCH report. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Boen JR; Nguyen PA; Williams SE; Matts JP
    Atherosclerosis; 2001 Jan; 154(1):221-7. PubMed ID: 11137103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein modification achieved by partial ileal bypass: five-year results of The Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1987 Aug; 102(2):424-32. PubMed ID: 3303402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Program on the Surgical Control of the Hyperlipidemias: a status report.
    Buchwald H; Moore RB; Matts JP; Long JM; Varco RL; Campbell GS; Pearce MB; Yellin AE; Blankenhorn DH; Holmes WL; Smink RD; Sawin HS
    Surgery; 1982 Oct; 92(4):654-62. PubMed ID: 6750834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Bourdages HR; Campos CT; Nguyen P; Williams SE; Boen JR
    Surgery; 1996 Oct; 120(4):672-9. PubMed ID: 8862377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial infarction and percent arteriographic stenosis of culprit lesion: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Hunter DW; Tuna N; Williams SE; Boen JR; Hansen BJ; Titus JL; Campos CT
    Atherosclerosis; 1998 Jun; 138(2):391-401. PubMed ID: 9690924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.